⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MRKR News

Marker Therapeutics, Inc. Common Stock

Marker Therapeutics Announces Upcoming Presentations on MT-601 in Relapsed Non-Hodgkin and Hodgkin Lymphoma at the 67th ASH Annual Meeting